Mikayla Ballard
Family · Little Rock, ARNPI 1770358780
Payments from drug & device makers
Across 93 payments — averaging $24.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$675
- Braeburn Inc.$298
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$248
- Neurocrine Biosciences, Inc.$176
- Viiv Healthcare Company$170
- Otsuka America Pharmaceutical, Inc.$122
- plus $613 from 13 others
What the payments were for
- Food & beverage$2,302100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 20 | $675 |
| Braeburn Inc. | 6 | $298 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $248 |
| Neurocrine Biosciences, Inc. | 8 | $176 |
| Viiv Healthcare Company | 12 | $170 |
| Otsuka America Pharmaceutical, Inc. | 6 | $122 |
| Vanda Pharmaceuticals Inc. | 6 | $117 |
| AbbVie | 5 | $107 |
| Indivior Inc. | 3 | $89 |
| Alkermes, Inc. | 4 | $66 |
| EMD Serono, Inc. | 2 | $62 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Merck | 1 | $18 |
| Exact Sciences | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,302 in reported general payments places this provider in the 80th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 111 | $450,698 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 42 | $155,046 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 25 | $95,227 |
| DovatoDolutegravir Sodium/Lamivudine | 23 | $67,297 |
| JulucaDolutegravir/Rilpivirine | 14 | $49,804 |
| TivicayDolutegravir Sodium | 16 | $43,299 |
| DescovyEmtricitabine/Tenofov Alafenam | 18 | $42,445 |
| VivitrolNaltrexone Microspheres | 23 | $36,638 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 98 | $17,120 |
| OzempicSemaglutide | 15 | $13,702 |
| JardianceEmpagliflozin | 11 | $11,665 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,013 |
| Quetiapine Fumarate | 11 | $851 |
| ValacyclovirValacyclovir Hcl | 15 | $636 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $675 | $588,369154 claims |
| Viiv Healthcare CompanyTriumeq, Dovato, Juluca, Tivicay | $170 | $315,44695 claims |
| Alkermes, Inc.Vivitrol | $66 | $36,63823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,103 family providers in Arkansas.
Other family in Little Rock
- Anthony EcholsLittle Rock$25K
- Michael StirlingLittle Rock$23K
- Laura BarganierLittle Rock$17K
- Emily AllenLittle Rock$14K
- Brandy EasonLittle Rock$13K
- Matthew TaylorLittle Rock$10K
- Collene RogersLittle Rock$9K
- Morgan BittengleLittle Rock$9K
- Melissa BaldwinLittle Rock$8K
- Leah CarringtonRogers$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.